CCM
Consonance Capital Management Portfolio holdings
AUM
$7.28M
This Quarter Return
-2.44%
1 Year Return
-42.86%
3 Year Return
+319.33%
5 Year Return
+899.35%
10 Year Return
–
AUM
$1.01B
AUM Growth
+$1.01B
(-28%)
Cap. Flow
-$252M
Cap. Flow
% of AUM
-24.93%
Top 10 Holdings %
Top 10 Hldgs %
65.73%
Holding
37
New
7
Increased
7
Reduced
12
Closed
7
Top Buys
| 1 |
Globus Medical
GMED
|
$67.1M |
| 2 |
Tandem Diabetes Care
TNDM
|
$60.3M |
| 3 |
Align Technology
ALGN
|
$54.1M |
| 4 |
ARQL
Arqule Inc
ARQL
|
$28.4M |
| 5 |
Insulet
PODD
|
$25.7M |
Top Sells
| 1 |
Pacira BioSciences
PCRX
|
$122M |
| 2 |
Iovance Biotherapeutics
IOVA
|
$76M |
| 3 |
UroGen Pharma
URGN
|
$51.5M |
| 4 |
Vanda Pharmaceuticals
VNDA
|
$51.1M |
| 5 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
$44.5M |
Sector Composition
| 1 | Healthcare | 98.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMRN
1
Amarin Corp
AMRN
$311M
| $96.9M | 9.59% | 6,390,259 -2,223,564 | -26% | -$33.7M |
|
2
Catalyst Pharmaceutical
CPRX
$2.52B
| $94.9M | 9.39% | 17,875,655 | – | – |
|
3
United Therapeutics
UTHR
$13.8B
| $77.2M | 7.64% | 967,569 +196,800 | +26% | +$15.7M |
|
|
4
Globus Medical
GMED
$8.27B
| $67.1M | 6.64% | +1,313,177 | New | +$67.1M |
|
|
5
Tandem Diabetes Care
TNDM
$845M
| $60.3M | 5.97% | +1,022,257 | New | +$60.3M |
|
6
uniQure
QURE
$896M
| $56.2M | 5.56% | 1,428,202 -483,327 | -25% | -$19M |
|
7
Karyopharm Therapeutics
KPTI
$61.7M
| $56.2M | 5.56% | 5,837,434 +34,207 | +0.6% | +$329K |
|
8
Vericel Corp
VCEL
$1.83B
| $55.2M | 5.46% | 3,644,492 +712,340 | +24% | +$10.8M |
|
|
9
Align Technology
ALGN
$10.3B
| $54.1M | 5.35% | +299,000 | New | +$54.1M |
|
10
Omeros
OMER
$283M
| $46.2M | 4.57% | 2,831,109 -220,813 | -7% | -$3.61M |
|
|
EPZM
11
DELISTED
Epizyme, Inc
EPZM
| $41M | 4.06% | 3,975,054 -785,005 | -16% | -$8.1M |
|
|
OXFD
12
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $35.7M | 3.53% | 2,144,524 -199,000 | -8% | -$3.31M |
|
13
STAAR Surgical
STAA
$1.36B
| $31.7M | 3.13% | 1,227,771 +743,214 | +153% | +$19.2M |
|
|
14
Iovance Biotherapeutics
IOVA
$807M
| $30.6M | 3.02% | 1,679,327 -4,173,509 | -71% | -$76M |
|
|
ARQL
15
DELISTED
Arqule Inc
ARQL
| $28.8M | 2.85% | 4,011,342 +3,961,342 | +7,923% | +$28.4M |
|
|
KDMN
16
DELISTED
Kadmon Holdings, Inc.
KDMN
| $26.9M | 2.67% | 10,693,574 -934,326 | -8% | -$2.35M |
|
17
Travere Therapeutics
TVTX
$1.56B
| $26.8M | 2.65% | 2,314,421 -1,498,095 | -39% | -$17.4M |
|
|
18
Insulet
PODD
$23.9B
| $25.7M | 2.54% | +155,800 | New | +$25.7M |
|
19
ADMA Biologics
ADMA
$4.12B
| $22.8M | 2.25% | 5,114,986 -590,366 | -10% | -$2.63M |
|
20
CareDx
CDNA
$727M
| $16.4M | 1.62% | +726,128 | New | +$16.4M |
|
21
Aurinia Pharmaceuticals
AUPH
$1.58B
| $13.7M | 1.35% | 2,561,269 -1,661,289 | -39% | -$8.87M |
|
|
CCXI
22
DELISTED
ChemoCentryx, Inc.
CCXI
| $11.3M | 1.12% | 1,666,667 | – | – |
|
23
ANI Pharmaceuticals
ANIP
$2.03B
| $10.4M | 1.03% | 142,943 | – | – |
|
24
Mustang Bio
MBIO
$10.9M
| $10.3M | 1.02% | 3,160,000 -215,000 | -6% | -$701K |
|
25
Krystal Biotech
KRYS
$4.27B
| $7.78M | 0.77% | 224,090 +42,000 | +23% | +$1.46M |
|